Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Budesonide Market Research Report 2025

Global Budesonide Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-16

Pages: 91 Pages

Report ld: 3473073

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Budesonide Market Size(US$)

CAGR 2025-2031

3.2%

Market Size,2031

USD 10,850

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 8,984 million

Market Forecast in 2031(Value)

US$ 10,850 million

CAGR

3.2%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Budesonide was valued at US$ 8732 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn"s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.

The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Budesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Budesonide.

The Budesonide market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Budesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Budesonide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

AstraZeneca

Teva

Mylan

Sandoz

Cosmo Pharmaceuticals

Salix

Chiesi Farmaceutici

Orion Corporation

Cipla

Synmosa Biopharma

Lunan Better Pharma

Shanghai Sine Promod

Segment by Type

Injectable Suspension

Aerosols

Inhalation Powder

Tablet and Capsule

Segment by Application

Respiratory Disease Treatment

Nose Disease Treatment

Inflammatory Bowel Disease Treatment

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Budesonide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Budesonide Market Overview

1.1 Product Definition

1.2 Budesonide by Type

1.2.1 Global Budesonide Market Value Comparison by Type (2024 VS 2031)

1.2.2 Injectable Suspension

1.2.3 Aerosols

1.2.4 Inhalation Powder

1.2.5 Tablet and Capsule

1.3 Budesonide by Application

1.3.1 Global Budesonide Market Value by Application (2024 VS 2031)

1.3.2 Respiratory Disease Treatment

1.3.3 Nose Disease Treatment

1.3.4 Inflammatory Bowel Disease Treatment

1.3.5 Others

1.4 Global Budesonide Market Size Estimates and Forecasts

1.4.1 Global Budesonide Revenue 2020-2031

1.4.2 Global Budesonide Sales 2020-2031

1.4.3 Global Budesonide Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Budesonide Market Competition by Manufacturers

2.1 Global Budesonide Sales Market Share by Manufacturers (2020-2025)

2.2 Global Budesonide Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Budesonide Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Budesonide, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Budesonide, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Budesonide, Product Type & Application

2.7 Global Key Manufacturers of Budesonide, Date of Enter into This Industry

2.8 Global Budesonide Market Competitive Situation and Trends

2.8.1 Global Budesonide Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Budesonide Players Market Share by Revenue

2.8.3 Global Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Budesonide Market Scenario by Region

3.1 Global Budesonide Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Budesonide Sales by Region: 2020-2031

3.2.1 Global Budesonide Sales by Region: 2020-2025

3.2.2 Global Budesonide Sales by Region: 2026-2031

3.3 Global Budesonide Revenue by Region: 2020-2031

3.3.1 Global Budesonide Revenue by Region: 2020-2025

3.3.2 Global Budesonide Revenue by Region: 2026-2031

3.4 North America Budesonide Market Facts & Figures by Country

3.4.1 North America Budesonide Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Budesonide Sales by Country (2020-2031)

3.4.3 North America Budesonide Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Budesonide Market Facts & Figures by Country

3.5.1 Europe Budesonide Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Budesonide Sales by Country (2020-2031)

3.5.3 Europe Budesonide Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Budesonide Market Facts & Figures by Region

3.6.1 Asia Pacific Budesonide Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Budesonide Sales by Region (2020-2031)

3.6.3 Asia Pacific Budesonide Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Budesonide Market Facts & Figures by Country

3.7.1 Latin America Budesonide Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Budesonide Sales by Country (2020-2031)

3.7.3 Latin America Budesonide Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Budesonide Market Facts & Figures by Country

3.8.1 Middle East and Africa Budesonide Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Budesonide Sales by Country (2020-2031)

3.8.3 Middle East and Africa Budesonide Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Budesonide Sales by Type (2020-2031)

4.1.1 Global Budesonide Sales by Type (2020-2025)

4.1.2 Global Budesonide Sales by Type (2026-2031)

4.1.3 Global Budesonide Sales Market Share by Type (2020-2031)

4.2 Global Budesonide Revenue by Type (2020-2031)

4.2.1 Global Budesonide Revenue by Type (2020-2025)

4.2.2 Global Budesonide Revenue by Type (2026-2031)

4.2.3 Global Budesonide Revenue Market Share by Type (2020-2031)

4.3 Global Budesonide Price by Type (2020-2031)

5 Segment by Application

5.1 Global Budesonide Sales by Application (2020-2031)

5.1.1 Global Budesonide Sales by Application (2020-2025)

5.1.2 Global Budesonide Sales by Application (2026-2031)

5.1.3 Global Budesonide Sales Market Share by Application (2020-2031)

5.2 Global Budesonide Revenue by Application (2020-2031)

5.2.1 Global Budesonide Revenue by Application (2020-2025)

5.2.2 Global Budesonide Revenue by Application (2026-2031)

5.2.3 Global Budesonide Revenue Market Share by Application (2020-2031)

5.3 Global Budesonide Price by Application (2020-2031)

6 Key Companies Profiled

6.1 AstraZeneca

6.1.1 AstraZeneca Company Information

6.1.2 AstraZeneca Description and Business Overview

6.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.1.4 AstraZeneca Budesonide Product Portfolio

6.1.5 AstraZeneca Recent Developments/Updates

6.2 Teva

6.2.1 Teva Company Information

6.2.2 Teva Description and Business Overview

6.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Teva Budesonide Product Portfolio

6.2.5 Teva Recent Developments/Updates

6.3 Mylan

6.3.1 Mylan Company Information

6.3.2 Mylan Description and Business Overview

6.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Mylan Budesonide Product Portfolio

6.3.5 Mylan Recent Developments/Updates

6.4 Sandoz

6.4.1 Sandoz Company Information

6.4.2 Sandoz Description and Business Overview

6.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sandoz Budesonide Product Portfolio

6.4.5 Sandoz Recent Developments/Updates

6.5 Cosmo Pharmaceuticals

6.5.1 Cosmo Pharmaceuticals Company Information

6.5.2 Cosmo Pharmaceuticals Description and Business Overview

6.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Cosmo Pharmaceuticals Budesonide Product Portfolio

6.5.5 Cosmo Pharmaceuticals Recent Developments/Updates

6.6 Salix

6.6.1 Salix Company Information

6.6.2 Salix Description and Business Overview

6.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Salix Budesonide Product Portfolio

6.6.5 Salix Recent Developments/Updates

6.7 Chiesi Farmaceutici

6.7.1 Chiesi Farmaceutici Company Information

6.7.2 Chiesi Farmaceutici Description and Business Overview

6.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Chiesi Farmaceutici Budesonide Product Portfolio

6.7.5 Chiesi Farmaceutici Recent Developments/Updates

6.8 Orion Corporation

6.8.1 Orion Corporation Company Information

6.8.2 Orion Corporation Description and Business Overview

6.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Orion Corporation Budesonide Product Portfolio

6.8.5 Orion Corporation Recent Developments/Updates

6.9 Cipla

6.9.1 Cipla Company Information

6.9.2 Cipla Description and Business Overview

6.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Cipla Budesonide Product Portfolio

6.9.5 Cipla Recent Developments/Updates

6.10 Synmosa Biopharma

6.10.1 Synmosa Biopharma Company Information

6.10.2 Synmosa Biopharma Description and Business Overview

6.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Synmosa Biopharma Budesonide Product Portfolio

6.10.5 Synmosa Biopharma Recent Developments/Updates

6.11 Lunan Better Pharma

6.11.1 Lunan Better Pharma Company Information

6.11.2 Lunan Better Pharma Description and Business Overview

6.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Lunan Better Pharma Budesonide Product Portfolio

6.11.5 Lunan Better Pharma Recent Developments/Updates

6.12 Shanghai Sine Promod

6.12.1 Shanghai Sine Promod Company Information

6.12.2 Shanghai Sine Promod Description and Business Overview

6.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Shanghai Sine Promod Budesonide Product Portfolio

6.12.5 Shanghai Sine Promod Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Budesonide Industry Chain Analysis

7.2 Budesonide Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Budesonide Production Mode & Process Analysis

7.4 Budesonide Sales and Marketing

7.4.1 Budesonide Sales Channels

7.4.2 Budesonide Distributors

7.5 Budesonide Customer Analysis

8 Budesonide Market Dynamics

8.1 Budesonide Industry Trends

8.2 Budesonide Market Drivers

8.3 Budesonide Market Challenges

8.4 Budesonide Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Budesonide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Budesonide Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Budesonide Market Competitive Situation by Manufacturers in 2024

Table 4. Global Budesonide Sales (M Units) of Key Manufacturers (2020-2025)

Table 5. Global Budesonide Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Budesonide Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Budesonide Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Budesonide Average Price (USD/K Units) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Budesonide, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Budesonide, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Budesonide, Product Type & Application

Table 12. Global Key Manufacturers of Budesonide, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Budesonide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Budesonide Sales by Region (2020-2025) & (M Units)

Table 18. Global Budesonide Sales Market Share by Region (2020-2025)

Table 19. Global Budesonide Sales by Region (2026-2031) & (M Units)

Table 20. Global Budesonide Sales Market Share by Region (2026-2031)

Table 21. Global Budesonide Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Budesonide Revenue Market Share by Region (2020-2025)

Table 23. Global Budesonide Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Budesonide Revenue Market Share by Region (2026-2031)

Table 25. North America Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Budesonide Sales by Country (2020-2025) & (M Units)

Table 27. North America Budesonide Sales by Country (2026-2031) & (M Units)

Table 28. North America Budesonide Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Budesonide Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Budesonide Sales by Country (2020-2025) & (M Units)

Table 32. Europe Budesonide Sales by Country (2026-2031) & (M Units)

Table 33. Europe Budesonide Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Budesonide Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Budesonide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Budesonide Sales by Region (2020-2025) & (M Units)

Table 37. Asia Pacific Budesonide Sales by Region (2026-2031) & (M Units)

Table 38. Asia Pacific Budesonide Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Budesonide Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Budesonide Sales by Country (2020-2025) & (M Units)

Table 42. Latin America Budesonide Sales by Country (2026-2031) & (M Units)

Table 43. Latin America Budesonide Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Budesonide Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Budesonide Sales by Country (2020-2025) & (M Units)

Table 47. Middle East and Africa Budesonide Sales by Country (2026-2031) & (M Units)

Table 48. Middle East and Africa Budesonide Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Budesonide Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Budesonide Sales (M Units) by Type (2020-2025)

Table 51. Global Budesonide Sales (M Units) by Type (2026-2031)

Table 52. Global Budesonide Sales Market Share by Type (2020-2025)

Table 53. Global Budesonide Sales Market Share by Type (2026-2031)

Table 54. Global Budesonide Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Budesonide Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Budesonide Revenue Market Share by Type (2020-2025)

Table 57. Global Budesonide Revenue Market Share by Type (2026-2031)

Table 58. Global Budesonide Price (USD/K Units) by Type (2020-2025)

Table 59. Global Budesonide Price (USD/K Units) by Type (2026-2031)

Table 60. Global Budesonide Sales (M Units) by Application (2020-2025)

Table 61. Global Budesonide Sales (M Units) by Application (2026-2031)

Table 62. Global Budesonide Sales Market Share by Application (2020-2025)

Table 63. Global Budesonide Sales Market Share by Application (2026-2031)

Table 64. Global Budesonide Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Budesonide Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Budesonide Revenue Market Share by Application (2020-2025)

Table 67. Global Budesonide Revenue Market Share by Application (2026-2031)

Table 68. Global Budesonide Price (USD/K Units) by Application (2020-2025)

Table 69. Global Budesonide Price (USD/K Units) by Application (2026-2031)

Table 70. AstraZeneca Company Information

Table 71. AstraZeneca Description and Business Overview

Table 72. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 73. AstraZeneca Budesonide Product

Table 74. AstraZeneca Recent Developments/Updates

Table 75. Teva Company Information

Table 76. Teva Description and Business Overview

Table 77. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 78. Teva Budesonide Product

Table 79. Teva Recent Developments/Updates

Table 80. Mylan Company Information

Table 81. Mylan Description and Business Overview

Table 82. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 83. Mylan Budesonide Product

Table 84. Mylan Recent Developments/Updates

Table 85. Sandoz Company Information

Table 86. Sandoz Description and Business Overview

Table 87. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 88. Sandoz Budesonide Product

Table 89. Sandoz Recent Developments/Updates

Table 90. Cosmo Pharmaceuticals Company Information

Table 91. Cosmo Pharmaceuticals Description and Business Overview

Table 92. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 93. Cosmo Pharmaceuticals Budesonide Product

Table 94. Cosmo Pharmaceuticals Recent Developments/Updates

Table 95. Salix Company Information

Table 96. Salix Description and Business Overview

Table 97. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 98. Salix Budesonide Product

Table 99. Salix Recent Developments/Updates

Table 100. Chiesi Farmaceutici Company Information

Table 101. Chiesi Farmaceutici Description and Business Overview

Table 102. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 103. Chiesi Farmaceutici Budesonide Product

Table 104. Chiesi Farmaceutici Recent Developments/Updates

Table 105. Orion Corporation Company Information

Table 106. Orion Corporation Description and Business Overview

Table 107. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 108. Orion Corporation Budesonide Product

Table 109. Orion Corporation Recent Developments/Updates

Table 110. Cipla Company Information

Table 111. Cipla Description and Business Overview

Table 112. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 113. Cipla Budesonide Product

Table 114. Cipla Recent Developments/Updates

Table 115. Synmosa Biopharma Company Information

Table 116. Synmosa Biopharma Description and Business Overview

Table 117. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 118. Synmosa Biopharma Budesonide Product

Table 119. Synmosa Biopharma Recent Developments/Updates

Table 120. Lunan Better Pharma Company Information

Table 121. Lunan Better Pharma Description and Business Overview

Table 122. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 123. Lunan Better Pharma Budesonide Product

Table 124. Lunan Better Pharma Recent Developments/Updates

Table 125. Shanghai Sine Promod Company Information

Table 126. Shanghai Sine Promod Description and Business Overview

Table 127. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)

Table 128. Shanghai Sine Promod Budesonide Product

Table 129. Shanghai Sine Promod Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Budesonide Distributors List

Table 133. Budesonide Customers List

Table 134. Budesonide Market Trends

Table 135. Budesonide Market Drivers

Table 136. Budesonide Market Challenges

Table 137. Budesonide Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Budesonide

Figure 2. Global Budesonide Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Budesonide Market Share by Type: 2024 & 2031

Figure 4. Injectable Suspension Product Picture

Figure 5. Aerosols Product Picture

Figure 6. Inhalation Powder Product Picture

Figure 7. Tablet and Capsule Product Picture

Figure 8. Global Budesonide Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Budesonide Market Share by Application: 2024 & 2031

Figure 10. Respiratory Disease Treatment

Figure 11. Nose Disease Treatment

Figure 12. Inflammatory Bowel Disease Treatment

Figure 13. Others

Figure 14. Global Budesonide Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Budesonide Market Size (2020-2031) & (US$ Million)

Figure 16. Global Budesonide Sales (2020-2031) & (M Units)

Figure 17. Global Budesonide Average Price (USD/K Units) & (2020-2031)

Figure 18. Budesonide Report Years Considered

Figure 19. Budesonide Sales Share by Manufacturers in 2024

Figure 20. Global Budesonide Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Budesonide Players: Market Share by Revenue in Budesonide in 2024

Figure 22. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Budesonide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Budesonide Sales Market Share by Country (2020-2031)

Figure 25. North America Budesonide Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Budesonide Sales Market Share by Country (2020-2031)

Figure 29. Europe Budesonide Revenue Market Share by Country (2020-2031)

Figure 30. Germany Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Budesonide Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Budesonide Revenue Market Share by Region (2020-2031)

Figure 37. China Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Budesonide Sales Market Share by Country (2020-2031)

Figure 48. Latin America Budesonide Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Budesonide Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Budesonide Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Budesonide by Type (2020-2031)

Figure 58. Global Revenue Market Share of Budesonide by Type (2020-2031)

Figure 59. Global Budesonide Price (USD/K Units) by Type (2020-2031)

Figure 60. Global Sales Market Share of Budesonide by Application (2020-2031)

Figure 61. Global Revenue Market Share of Budesonide by Application (2020-2031)

Figure 62. Global Budesonide Price (USD/K Units) by Application (2020-2031)

Figure 63. Budesonide Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Budesonide in 2031? zhanKai

The global market size of Budesonide in 2031 was 10850 Million USD.

Which region is expected to have the highest market share? shouQi

What was the global market size of Budesonide in 2025? shouQi

Which companies rank high in the global Budesonide market? shouQi

What is the annual compound growth rate of the global Budesonide market size from 2025 to 2031? shouQi

Related Reports

Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Budesonide market is projected to grow from US$ 8994 million in 2025 to US$ 11245 million by 2032, at a CAGR of 3.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-08
Pages: 205
USD 4900.00
(Single User License)
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Budesonide market size was US$ 8994 million in 2025 and is forecast to reach a readjusted size of US$ 11245 million by 2032 with a CAGR of 3.2% during the forecast period 2026-2032.
Published Date: 2026-07-08
Pages: 170
USD 4250.00
(Single User License)
Global Budesonide Market Research Report 2026
The global Budesonide market was valued at US$ 8994 million in 2025 and is anticipated to reach US$ 11245 million by 2032, at a CAGR of 3.2% from 2026 to 2032.
Published Date: 2026-07-08
Pages: 155
USD 2900.00
(Single User License)
Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Budesonide was estimated to be worth US$ 8994 million in 2025 and is projected to reach US$ 11245 million, growing at a CAGR of 3.2% from 2026 to 2032.
Published Date: 2026-07-08
Pages: 167
USD 3950.00
(Single User License)
Global Budesonide Market Report, History and Forecast 2021-2032
The global market for Budesonide was valued at US$ 8984 million in the year 2023 and is projected to reach a revised size of US$ 11165 million by 2030, growing at a CAGR of 3.2% during the forecast period 2024-2030.
Published Date: 2026-06-17
Pages: 133
USD 3350.00
(Single User License)
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Budesonide market is projected to grow from US$ 8732 million in 2024 to US$ 10850 million by 2031, at a CAGR of 3.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 153
USD 4900.00
(Single User License)
Global Budesonide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Budesonide was estimated to be worth US$ 8732 million and is forecast to reach approximately US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 144
USD 5900.00
(Single User License)
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Budesonide market size was US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Budesonide was estimated to be worth US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 126
USD 3950.00
(Single User License)
Global Budesonide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
Published Date: 2024-04-17
Pages: 156
USD 5600.00
(Single User License)

Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Budesonide market is projected to grow from US$ 8994 million in 2025 to US$ 11245 million by 2032, at a CAGR of 3.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-08
Pages: 205
USD 4900.00 (Single User License)
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Budesonide market size was US$ 8994 million in 2025 and is forecast to reach a readjusted size of US$ 11245 million by 2032 with a CAGR of 3.2% during the forecast period 2026-2032.
Published: 2026-07-08
Pages: 170
USD 4250.00 (Single User License)
Global Budesonide Market Research Report 2026
The global Budesonide market was valued at US$ 8994 million in 2025 and is anticipated to reach US$ 11245 million by 2032, at a CAGR of 3.2% from 2026 to 2032.
Published: 2026-07-08
Pages: 155
USD 2900.00 (Single User License)
Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Budesonide was estimated to be worth US$ 8994 million in 2025 and is projected to reach US$ 11245 million, growing at a CAGR of 3.2% from 2026 to 2032.
Published: 2026-07-08
Pages: 167
USD 3950.00 (Single User License)
Global Budesonide Market Report, History and Forecast 2021-2032
The global market for Budesonide was valued at US$ 8984 million in the year 2023 and is projected to reach a revised size of US$ 11165 million by 2030, growing at a CAGR of 3.2% during the forecast period 2024-2030.
Published: 2026-06-17
Pages: 133
USD 3350.00 (Single User License)
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Budesonide market is projected to grow from US$ 8732 million in 2024 to US$ 10850 million by 2031, at a CAGR of 3.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 153
USD 4900.00 (Single User License)
Global Budesonide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Budesonide was estimated to be worth US$ 8732 million and is forecast to reach approximately US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 144
USD 5900.00 (Single User License)
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Budesonide market size was US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
USD 4250.00 (Single User License)
Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Budesonide was estimated to be worth US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 126
USD 3950.00 (Single User License)
Global Budesonide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
Published: 2024-04-17
Pages: 156
USD 5600.00 (Single User License)